Some people living with HIV and some state health officials are raising concerns about part of the federal effort to end the HIV epidemic: a new technology that analyzes blood samples to find emerging outbreaks. The critics say it’s too invasive and stigmatizing and might not be more effective than older public health approaches.
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven’t received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren’t sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.
Hospital-acquired pneumonia not tied to ventilators is one of the most common infections that strike within health care facilities. But few hospitals take steps to prevent it, which can be as simple as dutifully brushing patients’ teeth.
Public health officials say monkeypox is not as dangerous as covid and can be handled well with current treatments and if those at risk use caution. But the rollout of vaccines has been slow and led to angst among some at-risk people.
The pandemic disrupted all sense of normalcy for U.S. hospitals, so federal officials are proposing to pause financial penalties against the facilities and to block public access to key hospital safety data — such as the frequency of falls and sepsis — because of concerns that the data isn’t accurate enough. But consumer advocates are furious about the proposal.
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success and might have overshadowed the government’s covid-fighting strategy.
The Blackfeet Nation is experimenting with a new way to detect chronic wasting disease in animals used by tribal members for food and cultural practices.
For now, monkeypox poses a low risk to the U.S. public, but it could become a problem if the spread is left unchecked. Here’s what everyone should know about it.
For now, monkeypox poses a low risk to the U.S. public, but it could become a problem if the spread is left unchecked. Here’s what everyone should know about it.
One million Americans have died from covid-19 — far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nation’s pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.
